🇺🇸 formoterol - beclometasone in United States

11 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Dyspnoea — 2 reports (18.18%)
  2. Chronic Obstructive Pulmonary Disease — 1 report (9.09%)
  3. Condition Aggravated — 1 report (9.09%)
  4. Coronavirus Test Positive — 1 report (9.09%)
  5. Fall — 1 report (9.09%)
  6. Hepatitis Toxic — 1 report (9.09%)
  7. Hyperglycaemia — 1 report (9.09%)
  8. Insomnia — 1 report (9.09%)
  9. Lung Neoplasm Malignant — 1 report (9.09%)
  10. Pain In Extremity — 1 report (9.09%)

Source database →

formoterol - beclometasone in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is formoterol - beclometasone approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for formoterol - beclometasone in United States?

Università degli Studi di Brescia is the originator. The local marketing authorisation holder may differ — check the official source linked above.